VARIVAX - 0006-4826-00 - (Varicella Virus Vaccine Live)

Alphabetical Index


Drug Information of VARIVAX

Product NDC: 0006-4826
Proprietary Name: VARIVAX
Non Proprietary Name: Varicella Virus Vaccine Live
Active Ingredient(s): 1350    [PFU]/.5mL & nbsp;   Varicella Virus Vaccine Live
Administration Route(s): SUBCUTANEOUS
Dosage Form(s): INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION
Coding System: National Drug Codes(NDC)

Labeler Information of VARIVAX

Product NDC: 0006-4826
Labeler Name: Merck Sharp & Dohme Corp.
Product Type: VACCINE
FDA Application Number: BLA103552
Marketing Category: BLA
Start Marketing Date: 19950317

Package Information of VARIVAX

Package NDC: 0006-4826-00
Package Description: 1 VIAL, SINGLE-DOSE in 1 CARTON (0006-4826-00) > .5 mL in 1 VIAL, SINGLE-DOSE (0006-4826-01)

NDC Information of VARIVAX

NDC Code 0006-4826-00
Proprietary Name VARIVAX
Package Description 1 VIAL, SINGLE-DOSE in 1 CARTON (0006-4826-00) > .5 mL in 1 VIAL, SINGLE-DOSE (0006-4826-01)
Product NDC 0006-4826
Product Type Name VACCINE
Non Proprietary Name Varicella Virus Vaccine Live
Dosage Form Name INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION
Route Name SUBCUTANEOUS
Start Marketing Date 19950317
Marketing Category Name BLA
Labeler Name Merck Sharp & Dohme Corp.
Substance Name VARICELLA-ZOSTER VIRUS STRAIN OKA/MERCK LIVE ANTIGEN
Strength Number 1350
Strength Unit [PFU]/.5mL
Pharmaceutical Classes Live Attenuated Varicella Zoster Virus Vaccine [EPC],Actively Acquired Immunity [PE],Vaccines, Attenuated [Chemical/Ingredient],Chickenpox Vaccine [Chemical/Ingredient],Live Attenuated Herpes Zoster Virus Vaccine [EPC],Herpes Zoster Vaccine [Chemical/Ingredient]

Complete Information of VARIVAX


General Information